Introduction
Background
Minimal-change disease (MCD), also known as lipoid nephrosis or nil disease, is the most common single form of nephrotic syndrome in children. It refers to a histopathologic lesion in the glomerulus that almost always is associated with nephrotic syndrome. It typically is a disease of childhood, but it also can occur in adults.
Pathophysiology
It is postulated that MCD is a disorder of T cells, which release a cytokine that injures the glomerular epithelial foot processes. This, in turn, leads to a decreased synthesis of polyanions. The polyanions constitute the normal charge barrier to the filtration of macromolecules, such as albumin. When the polyanions are damaged, leakage of albumin follows. The identity of this circulating permeability factor is uncertain, although it is postulated that it may be hemopexin.
Some of the cytokines that have been studied in MCD are interleukin-12 (IL-12) and interleukin-4 (IL-4). IL-12 levels have been found to be elevated in peripheral blood monocytes during the active phase and normalized during remission. Interleukin-18 (IL-18) can synergize with IL-12 to selectively increase the production of vascular permeability factor from T cells. In addition, levels of IL-4 and CD23 (a receptor for immunoglobulin E) have been found to be elevated in peripheral blood lymphocytes.
Synaptopodin is a proline-rich protein intimately associated with actin microfilaments present in the foot processes of podocytes. Greater synaptopodin expression in podocytes is associated with a significantly better response to steroid therapy. On the other hand, the expression of synaptopodin does not predict progression of MCD or diffuse mesangial hypercellularity to focal segmental glomerulosclerosis (FSGS). Thus, this marker could be used in the future to help determine appropriate therapy.
Interleukin-13 (IL-13) has been implicated in the pathogenesis of MCD. In a study on Singapore Chinese children, it was shown that IL-13 genetic polymorphisms correlate with the long-term outcome of MCD.
In patients who develop acute renal failure, endothelin 1 expression is greater in the glomeruli, vessels, and tubules than in the nonacute renal failure group. The glomerular epithelial cells (podocytes) and the slit diaphragm connecting the podocyte foot processes play a primary role in the development of proteinuria.
Nephrin is a major component of the slit diaphragm. The slit diaphragm is often missing in MC nephrotic syndrome (MCD) kidneys. The role of nephrin and the slit diaphragm in MCD is not known. However, genetic variants of a glomerular filter protein may play a role in some patients with MCD.
Lack of glomerular dysferlin expression has been recently associated with minimal change nephropathy in a patient with limb-girdle muscular dystrophy type 2B. Two of the three patients with this disease had increased microalbuminuria.
Although there have been a multitude of studies recently published, the mechanism by which T cells increase glomerular permeability has remained unproven.
Frequency
United States
In preadolescents, minimal-change nephrotic syndrome (MCNS) makes up 85-95% of all causes of nephrotic syndrome. In adolescents and young adults, the prevalence is 50%. In the population older than 40 years, it is found in 20-25% of cases with nephrotic syndrome. Incidence is 2-7 new cases per 100,000 children, and the prevalence is 15 cases per 100,000 children.
Mortality/Morbidity
Very few patients progress to end-stage renal disease. These patients are those who have FSGS that has been misdiagnosed as MCD.
- Hypovolemic shock is perhaps the most serious complication of MCD. Hypovolemic shock typically occurs during the edema-forming phase of relapse and may be precipitated by diarrhea, sepsis, drainage of ascitic fluid, or the use of diuretics.
- Hypertension, somewhat paradoxically, also may occur in approximately 9-14% of children. Hypertension occurs in approximately 30% of adults, with a greater incidence in older patients (>60 y).
- Thromboembolic events are serious complications of nephrotic syndrome. Peripheral thrombosis may result in gangrene, and deep venous thrombosis in the legs or pelvic veins may be a source of pulmonary emboli. Bacterial infections, especially peritonitis, occur with greater frequency, partly because of the loss of immunoglobulin G (IgG) and complement factors B and D in the urine. In fact, the largest reduction in mortality in these patients follows the introduction of antibiotics rather than any specific therapy.
Race
- Asians may be at increased risk.
Sex
- It is found twice as frequently in boys than in girls.
- The frequency is the same between the sexes in adults.
Age
- The incidence peaks in children aged 2 years, with approximately 80% being younger than 6 years at the time of diagnosis.
- In adults, the mean age of onset is 40 years.
Clinical
History
- Edema may be preceded by an upper respiratory tract infection, an allergic reaction to a bee sting, or the use of certain drugs or malignancies.
- Facial edema is noted first.
- Malaise and easy fatigability can occur.
- Weight gain often is an additional feature.
- The patient also may present with the following:
- Hypovolemia
- Hypertension
- Thromboembolism
- Infection
Physical
- The blood pressure usually is normal in children but may be elevated in adults.
- Dependent edema is the most prominent sign. The retina has a wet appearance. Subungual edema with horizontal lines (called Muehrcke lines) also may occur.
- Hernias may be found, and the elasticity of the ears may be decreased.
- Heavy proteinuria over an extended period of time leads to a state of protein depletion with muscle wasting, thinning of the skin, and growth failure.
- Pleural and ascitic fluid can accumulate. Rarely, cellulitis, peritonitis, or pneumonia may be the first indication of an underlying nephrotic syndrome.
- Children may have growth failure.
Causes
Almost all cases are idiopathic, but a small percentage of cases (approximately 10-20%) may have an identifiable cause. Causes may include the following:
- Idiopathic
- Secondary
- Drugs - Nonsteroidal anti-inflammatory drugs (NSAIDs), rifampin, interferon, ampicillin/penicillin, trimethadione, mercury-containing cosmetic skin cream
- Toxins - Mercury, lithium, bee stings, fire coral exposure
- Infection - Infectious mononucleosis, HIV, immunization
- Tumor - Hodgkin lymphoma (most commonly), carcinoma, other lymphoproliferative diseases
- Posthematopoietic stem cell transplant
More on Minimal-Change Disease |
 Overview: Minimal-Change Disease |
| Differential Diagnoses & Workup: Minimal-Change Disease |
| Treatment & Medication: Minimal-Change Disease |
| Follow-up: Minimal-Change Disease |
| References |
| Next Page » |
References
Ahmad H, Tejani A. Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron. Apr 2000;84(4):342-6. [Medline].
Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, et al. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol. May 2006;21(5):603-10. [Medline].
Audard V, Larousserie F, Grimbert P, Abtahi M, Sotto JJ, Delmer A, et al. Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int. Jun 2006;69(12):2251-60. [Medline].
Bagga A, Hari P, Moudgil A, Jordan SC. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis. Dec 2003;42(6):1114-20. [Medline].
Bonilla-Felix M, Parra C, Dajani T, Ferris M, Swinford RD, Portman RJ, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children. Kidney Int. May 1999;55(5):1885-90. [Medline].
Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol. Apr 1999;13(3):199-204. [Medline].
Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int. Mar 2002;61(3):1098-114. [Medline].
Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D. Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant. Nov 2002;17(11):2011-3. [Medline].
Dijkman HB, Wetzels JF, Gemmink JH, Baede J, Levtchenko EN, Steenbergen EJ. Glomerular involution in children with frequently relapsing minimal change nephrotic syndrome: an unrecognized form of glomerulosclerosis?. Kidney Int. Jan 2007;71(1):44-52. [Medline].
Donia AF, Gazareen SH, Ahmed HA. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children. Nephrol Dial Transplant. Oct 2003;18(10):2054-8. [Medline].
Francois H, Daugas E, Bensman A, Ronco P. Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis. Jan 2007;49(1):158-61. [Medline].
Grimbert P, Audard V, Remy P, Lang P, Sahali D. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant. Feb 2003;18(2):245-8. [Medline].
Humphreys BD, Vanguri VK, Henderson J, Antin JH. Minimal-change nephrotic syndrome in a hematopoietic stem-cell transplant recipient. Nat Clin Pract Nephrol. Sep 2006;2(9):535-9;quiz 540. [Medline].
International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr. Apr 1981;98(4):561-4. [Medline].
Izzedine H, Brocheriou I, Eymard B, Le Charpentier M, Romero NB, Lenaour G, et al. Loss of podocyte dysferlin expression is associated with minimal change nephropathy. Am J Kidney Dis. Jul 2006;48(1):143-50. [Medline].
Jennette JC, Falk RJ. Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis. Nov 1990;16(5):432-7. [Medline].
Lahdenkari AT, Kestila M, Holmberg C, Koskimies O, Jalanko H. Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int. May 2004;65(5):1856-63. [Medline].
Matsumoto K, Kanmatsuse K. Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol. Aug 1999;117(2):361-7. [Medline].
Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. Mar 2002;39(3):503-12. [Medline].
Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J Pediatr. Dec 1994;125(6 Pt 1):981-6. [Medline].
Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int. Jun 1986;29(6):1215-23. [Medline].
Prasad GV, Vincent L, Hamilton R, Lim K. Minimal change disease in association with fire coral (Millepora species) exposure. Am J Kidney Dis. Jan 2006;47(1):e15-6. [Medline].
Sinha MD, MacLeod R, Rigby E, Clark AG Nov 25. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant. Jul 2006;21(7):1848-54Epub. [Medline].
Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis. Mar 1992;19(3):201-13. [Medline].
Tang HL, Chu KH, Mak YF, Lee W, Cheuk A, Yim KF, et al. Minimal change disease following exposure to mercury-containing skin lightening cream. Hong Kong Med J. Aug 2006;12(4):316-8. [Medline].
Tarshish P, Tobin JN, Bernstein J. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997 May; 8(5): 769-76[Medline]. J Am Soc Nephrol. 1997;8 (5):769-76. [Medline].
Wei CL, Cheung W, Heng CK, Arty N, Chong SS, Lee BW, et al. Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease. Nephrol Dial Transplant. Apr 2005;20(4):728-34. [Medline].
Further Reading
Keywords
MCD, idiopathic nephrotic syndrome of childhood, lipoid nephrosis, minimal-change nephropathy, minimal-change nephrotic syndrome, MCNS, nil disease, steroid-sensitive nephrotic syndrome
